BioCentury
ARTICLE | Clinical News

Hepsyl synthetic polymeric humate compounds regulatory update

October 18, 1999 7:00 AM UTC

Laub received U.S. Patent No. 5,945,446 covering synthetic polymeric humate compounds that are in preclinical development to treat viral infections including HIV, herpes simplex and influenza. ...